skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

2008 HSR&D National Meeting Abstract

National Meeting 2008

3007 — The Impact of the VA Medication Copayment Increase on Medicare and VA Outpatient Utilization

Smith KT (CMC3/Hines VA), Stroupe TA (CMC3/Hines VA), Tarlov E (CMC3/Hines VA), Huo Z (CMC3/Hines VA), Hynes DM (CMC3/Hines VA), Weiss KB (CMC3/Hines VA)

On February 2002, the medication copayment for VA pharmacies increased from $2 to $7 per 30-day supply. Based on characteristics such as level of disability, service connection status, and income veterans pay copayments for some, all, or none of their medications obtained from VA. These changes resulted in decrease in medication acquisition, but the impact on outpatient utilization is unknown. The objective of this study was to examine the association between level of copayment changes in VA and Medicare primary (e.g., general internal medicine) and specialty (e.g., cardiology, nephrology) outpatient utilization in the year following the copayment increase.

We collected both VA and Medicare utilization data for 69,440 male veterans over age 65 for the years before and after the VA medication copayment increase. The study design was a retrospective observational study. Multivariable zero-inflated negative binomial regression models were used to examine the association between level of copayment for VA medications and the number of VA and Medicare primary and specialty outpatient visits.

Overall, the mean number of visits to VA in the year following the copayment increase decreased for primary (.15 visits) and specialty care (.23 visits). During that same time, the mean number of visits by veterans to Medicare providers increased for both types of visits (.52 primary visits, 1.3 specialty visits). Veterans with copayments for some medications had a bigger increase in Medicare specialty visits in the year after the copayment increase (IRR=1.07, CI: 1.01 - 1.13, p=0.029) than veterans who did not have copayments; the result for veterans with copayments for all medications was almost identical. There were no statistically significant (p < 0.01) associations between copayment levels and the number of Medicare primary visits, VA primary visits, or VA specialty visits.

After the copayment increase, veterans who had copayments for some or all of their medications had a larger increase in Medicare specialty visits than veterans who had no medication copayments.

Medication copayments affect both the amount of medications received and patterns of utilization of outpatient services. These results highlight the importance of considering both direct and indirect consequences of a policy change.

Questions about the HSR&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.